Spine Biologics Market Size & Share 2023 to 2032
Market Size by Product [Bone Graft (Allograft, Autograft), Bone Graft Substitutes (Demineralized Bone Matrix, Synthetic Bone Graft), Platelet Rich Plasma], Surgery (ACDF, PLIF, TLIF).
Report ID: GMI6096
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Spine Biologics Market Size
Spine Biologics Market size in 2022 was valued at USD 2.2 billion in 2022 and is expected to witness CAGR of 4.3% by 2032 owing to increasing prevalence of spine deformities, growing awareness and patient preference for minimally invasive procedures, and technological advancements.
Spine Biologics Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Spine biologics refer to a type of medical treatments or therapies that are developed by using biological materials or substances for treating various spinal conditions and disorders. They are used as alternatives to traditional surgical techniques, and provide biological support by promoting bone healing, fusion, and regeneration of the spine. They facilitate in reducing pain, improve functioning and better quality of life.
COVID-19 Impact
The COVID-19 pandemic has had a significant impact on the spine biologics market. During the pandemic, due to the implementation of lockdown and travel restrictions, many elective surgeries, including spinal procedures, were either postponed or cancelled in order to reduce the risk of infection. It reduced the number of spine surgeries performed and a temporary decline in the demand for spine biologics. The pandemic caused disruption in the global supply chain, leading to a decrease in the production and distribution of spine biologics. Manufacturing facilities experienced challenges in maintaining normal operations, affecting production, which led to potential shortages or delays in the availability of spine biologic products.
With the vaccination efforts and infection control measures implemented to reduce the risk of infection, elective surgeries, including spine procedures. The backlog of postponed surgeries has created an increasing demand, leading to the recovery of the utilization of spine biologics. The pandemic has brought attention to the benefits of minimally invasive procedures, such as smaller incisions, fewer hospitalizations, and rapid recovery times. Spine biologics used in conjunction with minimally invasive techniques are expected to increase in demand due to the growing awareness and patient preference for such approaches.
Spine Biologics Market Driving Factors
The increasing prevalence of spinal disorders, rising geriatric population, growing demand for minimally invasive procedures are the major factors contributing to the overall expansion of this market. The geriatric population is more likely to develop spinal disorders such as degenerative disc disease, spinal stenosis, and osteoporosis-related fractures. Such conditions often need surgical intervention which involves utilization of spine biologics. The growing geriatric population, thus result in increased demand for spine surgeries associated with biologics. The surgical techniques and technologies have advanced with the time, that makes spine surgeries safer and more effective treatment option for such patients. The utilization of spine biologics helps in improving the fusion process, surgical outcomes, and minimize risk associated with spine surgeries in geriatric patients.
Spine Biologics Market Analysis
Based on products, the spine biologics market is segmented into bone grafts, bone graft substitutes, platelet-rich plasma, bone marrow aspirate therapy, and other products. The bone graft segment is further sub-segmented into allografts and autografts. The bone graft substitute segment is further sub-segmented into demineralized bone matrix, synthetic bone grafts, and bone morphogenetic proteins. The bone graft substitutes segment accounted for the largest market share of 64.1% in 2022. In addition to this, it reduces the risk associated with the disease transmission, has osteoconductive properties, osteoinductive potential, and offers the structural integrity and stability.
Based on surgery type, the spine biologics market is classified into anterior cervical discectomy and fusion, posterior lumbar interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, lateral lumbar interbody fusion, and other surgery types. The anterior cervical discectomy and fusion segment was valued at USD 834.9 million in 2022. It is an effective treatment option for relieving pain caused by cervical disc disease. Most patients experience significant pain relief immediately after this surgery. They also help improve the functioning and movement of arms and hands.
Based on end-user, the spine biologics market is sub-divided into hospitals, ambulatory surgical centres, and other end-users. Hospitals segment is expected grow at CAGR of 4.1% by 2032. The hospitals are equipped with comprehensive healthcare facilities, including specialized departments and multidisciplinary teams that can provide a full range of spine care services. This includes diagnostics, surgical interventions, and post-operative care, making hospitals an attractive choice for patients requiring spine biologics. In addition to this, the hospitals typically have established relationships with insurance providers and can facilitate insurance coverage and reimbursement processes for patients undergoing spine biologics procedures. This industry it easier for patients to access and afford these treatments.
Based on the region, North America spine biologics market is expected to reach USD 1.4 billion by 2032. The region has a relatively high prevalence of spinal conditions, such as degenerative disc disease, spinal stenosis, and spinal deformities. This results in a significant patient pool for surgical interventions, such as the use of spine biologics. In addition to this, North America has a well-developed healthcare system, presence of prominent players in this business, and increased awareness and demand for minimally invasive procedures.
Spine Biologics Market Share
The key players in the spine biologics market are
Spine Biologics Industry News:
The spine biologics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
By Surgery Type
By End-user
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →